When is the next results date for Hindustan Bio Sciences Ltd?
2026-07-23 23:16:55The next results date for Hindustan Bio Sciences Ltd is scheduled for July 31, 2026....
Read full news articleAre Hindustan Bio Sciences Ltd latest results good or bad?
2026-06-02 19:28:22Hindustan Bio Sciences Ltd has reported concerning financial results for the quarter ended March 2026, reflecting significant operational challenges. The company recorded net sales of ₹0.00 crores, a complete decline from ₹0.38 crores in the previous quarter, indicating a 100% quarter-on-quarter drop. This pattern of alternating quarters with zero revenue raises serious concerns about the company's operational viability and market presence. In terms of profitability, Hindustan Bio Sciences experienced a net loss of ₹0.12 crores in Q4 FY26, a stark contrast to the net profit of ₹0.08 crores reported in the prior quarter. The operating profit before depreciation, interest, and tax (PBDIT) also stood at negative ₹0.12 crores, highlighting the company's inability to cover basic operational expenses without revenue generation. The company's return on equity (ROE) was reported at 8.60%, with the latest quarter ...
Read full news article
Hindustan Bio Sciences Q4 FY26: Revenue Collapse Signals Deepening Operational Crisis
2026-06-01 15:05:42Hindustan Bio Sciences Ltd. reported a complete revenue collapse in Q4 FY26, with net sales plummeting to zero from ₹0.38 crores in the previous quarter, whilst simultaneously posting a net loss of ₹0.12 crores. The micro-cap pharmaceutical company, valued at just ₹8.32 crores, saw its shares decline 4.47% to ₹8.12 following the dismal quarterly performance, extending its one-year loss to 17.23%.
Read full news articleAre Hindustan Bio Sciences Ltd latest results good or bad?
2026-05-30 19:45:11Hindustan Bio Sciences Ltd's latest financial results for Q3 FY26 indicate a complex operational landscape characterized by significant revenue volatility and structural challenges. The company reported net sales of ₹0.38 crores, a recovery from zero sales in the previous quarter, which underscores the erratic nature of its revenue generation. This pattern raises concerns about the sustainability of its business model, especially given the company's five-year sales growth rate of -16.00%. The net profit for the quarter was ₹0.08 crores, marking a recovery from a loss of ₹0.06 crores in the prior quarter. This profit recovery, while positive, is set against a backdrop of historical inconsistency, as the average return on equity (ROE) over recent years stands at 0.0%. The latest quarter's ROE of 14.00% reflects better capital efficiency when the company is operational, but this is not indicative of a stable ...
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
03-Aug-2026 | Source : BSENewspaper Publication of un-audited financial results for the quarter ended 30th June 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday July 31 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulation 2015
31-Jul-2026 | Source : BSEOutcome of the Board Meeting held on Friday July 31 2026 as Required under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015
Results For The Quarter Ended 30Th June 2026
31-Jul-2026 | Source : BSEApproval of Un-audited Financial Results of the company for the first quarter ended 30 june 2026 along with Limited Review Report issued by statutory auditor
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






